6998 — Genor Biopharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Genor Biopharma Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2,930	2,201	1,589	1,165	1,059
Net Total Receivables	136	133	82.7	68.6	8.5
Total Inventory
Total Other Current Assets
Total Current Assets	3,101	2,387	1,720	1,241	1,067
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	229	223	205	60.1	5.82
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3,573	2,863	2,115	1,447	1,290
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	249	313	260	230	122
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	339	373	313	258	138
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	3,234	2,490	1,802	1,189	1,151
Total Liabilities & Shareholders' Equity	3,573	2,863	2,115	1,447	1,290
Total Common Shares Outstanding